Avoro Capital Advisors LLC 13D/13G Filings for Definium Therapeutics, Inc. (DFTX)

Avoro Capital Advisors LLC 13D and 13G filings for Definium Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-02-17
09:00 am
Purchase
2025-12-3113GDefinium Therapeutics, Inc.
DFTX
Avoro Capital Advisors LLC5,000,000
5.080%
5,000,000increase
(New Position)
Filing